Home/Pipeline/Noa‑002

Noa‑002

Chronic Inflammatory Skin Disorders

PreclinicalActive

Key Facts

Indication
Chronic Inflammatory Skin Disorders
Phase
Preclinical
Status
Active
Company

About Noa Therapeutics

A biotech startup using biased AhR modulation to create disease‑modifying small‑molecule therapies for chronic inflammation.

View full company profile